1,135
Participants
Start Date
December 31, 2005
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
NES/EE CVR
This is a Phase 3, multicenter, open-label study of a 21/7-day regimen of the 150/15 NES/EE CVR, in healthy women followed on an outpatient basis up to one year (13 cycles) of treatment over one year. Because of the stop treatment date of December 31, 2008 for all participants, women enrolling or re-enrolling in 2008 may not complete a full 13 cycles of treatment. Subjects may also participate in a 6 month follow-up period after the 300B study. The ring is designed to last for 12 months.
Montefiore Medical Center/Albert Einstein College of Medicine, The Bronx
Columbus Center for Women's Heatlh Research, Columbus
University of Chicago Hospitals, Chicago
Women and Children's Hospital, LAC/USC Medical Center, Los Angeles
University of California, San Francisco General Hospital, Department of Obstetrics & Gynecology, San Francisco
FPA Health, Ashfield
University of Campinas, Department of Obstetrics & Gynecology, São Paulo
Instituto Chileno de Medicina Reproductiva, Santiago
Profamilia, Santo Domingo
Family Federation of Finland, Helsinki
University of Szeged, Department of Obstetrics & Gynecology, Szeged
Karolinska Institutet, Department of Woman and Child Health, Division of Obstetrics & Gynecology, Stockholm
United States Agency for International Development (USAID)
FED
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
World Health Organization
OTHER
Population Council
OTHER